MorphoSys AG (MPSYF) Stock Analysis
DELISTED
What happened to MorphoSys AG (MPSYF) stock?
MorphoSys AG (MPSYF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $2.76B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
MorphoSys AG (MPSYF). MorphoSys AG is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing therapeutic antibodies for cancer and autoimmune diseases.
Last analyzed: Mar 17, 2026Dated analysis: the newest financial statements on file are 31 months old (Mar 1, 2024), so the figures and score below describe that period, not today.
MorphoSys AG (MPSYF) Healthcare & Pipeline Overview
MPSYF OTC Market Information
MPSYF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy MPSYF shares?
No. MPSYF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for MPSYF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MPSYF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to MorphoSys AG. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.